Table 2.
The Active Molecular Screening Results of Patients on Admission and Drug Resistance Rate of CR-KP Colonization/Infection of the Whole Hospital and the EICU
| (A) | ||||
|---|---|---|---|---|
| EICU | 2017.5–2018.4 (Baseline) | 2018.5–2019.4 | 2019.5–2020.4 | 2020.5–2021.4 |
| Screening positive rate | 15.18% (34/224) | 18.53% (43/232) | 12.64% (21/174) | |
| blaKPC | 18 | 24 | 10 | |
| blaNDM | 22 | 22 | 12 | |
| blaOXA-48 | 0 | 1 | 0 | |
| KPN | 28 | 20 | 21 | 30 |
| CR-KP | 20 | 15 | 14 | 14 |
| CR rate | 71.43% | 75% | 66.67% | 46.67% |
| (B) | ||||
| Hospital-wide | 2017.5–2018.4 (Baseline) | 2018.5–2019.4 | 2019.5–2020.4 | 2020.5–2021.4 |
| KPN | 269 | 228 | 248 | 281 |
| CR-KP | 123 | 119 | 113 | 147 |
| CR rate | 45.72% | 52.19% | 45.56% | 52.31% |
| ΔCR ratea | 25.71% | 22.81% | 21.11% | 4.64% |
Notes: aΔCR rate means the gap between drug resistance rate of the EICU and the whole hospital. A. The resistance rate of CR-KP colonization and infection identified by routine clinical culture detection significantly decreased from 71.43% to 46.67%. B. Comparing with the rate of the whole hospital, the drug resistance ratio gaps between EICU and the whole hospital were narrowed from 22.81%, 21.11% to 4.64% year by year.